Navigation Links
'Risperdal' Cleared By FDA To Treat Autistic Children

'Risperdal' (Risperidone) an antipsychotic drug has been for the first time given the green signal to be implemented for symptomatic treatment of emotional disturbances// in children and teenagers suffering from Autism, by The U.S. Food and Drug Administration.

An antipsychotic drug generally employed in the treatment of adults, Risperidone will thus become the first one in its league to be used in treating children affected with Autism.

Risperdal was first approved and implemented in the short-term treatment of Schizophrenia in adults way back in 1993. In 2003 it was cleared for short term treatment of mania and mixed outbreaks of extreme mood swings as well.. Now the FDA has cleared this drug to be safely implemented in the treatment of behavior disorders in autistic children that suggest irritability, which includes temper tantrums, attempted self-mutilation, and aggression.

Its compatibility to treat irritability and aggression in children was proved in a series of tests conducted in two 8-week, placebo-controlled trials done amongst 156 patients between ages 5-16. The results of the battery of tests showed remarkable improvement in symptoms associated with irritability in autistic children given Risperidone as opposed to those given placebo who showed no improvement. Common side effects encountered with the use of this drug are drowsiness, tiredness, constipation and weight gain.

Steven Galson, M.D., director of FDA's Center for Drug Evaluation and Research was hopeful that this drug would be of great benefit for many autistic children. He also emphasized that the agency he represents firmly believes in encouraging development of apt drugs that can be employed in treating children, which were hitherto used among adults.

Source-Eurekalert
'"/>




Page: 1

Related medicine news :

1. FDA Gives the Nod to Risperdal For Use in Autistic Children
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. The Decks Cleared For HRT - Safe for Menopause Symptoms
4. Doctor Cleared Of Charges of Killing a baby
5. Orissa Villagers Jubilant as Girl Cleared Class X Examination
6. Patent for Seminal RNAi innovation Cleared in Australia
7. Aricept Cleared for Advanced Alzheimers Treatment
8. A Woman Dies Due to Breast Cancer After Being Cleared in the Breast Scan
9. Drug For Iron Overload Cleared
10. Advances in Treatment of Cataracts
11. Recommendations for Treatment of Blood Pressue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... North American CAREGiverSM of the Year for her extraordinary compassion and lifelong dedication ... 60,000 North American professional caregivers for the prestigious award each year – identifying ...
(Date:4/27/2017)... ... ... Offering the purest product of its kind, Swissx Labs AG has launched ... the market has seen before. Swissx uses proprietary strains of hemp plants grown in ... for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. Learn ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., an ... it has completed a round of funding to accelerate its growth strategies. The ... Granite Capital is a growth equity firm focused on investments in healthcare and ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... to announce the ATA 2017 President’s Awards recipients, comprised of organizations and ... healthcare delivery. , The ATA 2017 President’s Awards recognize individuals and ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/18/2017)... DIEGO and BLOOMINGTON, Minn. ... Inc. (NASDAQ: IMMY ) ("Imprimis"), an ... Precision Lens ("Precision Lens"), today announced the signing ... the agreement, Precision Lens will deploy a dedicated ... select geographies in the U.S., primarily focused in ...
(Date:4/18/2017)... , April 18, 2017 Research and ... the United States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast ... ... molecular imaging equipment revenues as well as growth in the ... will provide value to market participants that design and manufacture ...
Breaking Medicine Technology: